CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2

Credit to Download: 1 | Page Numbers 10 | Abstract Views: 31
Year: 2020
COI code: JR_TIPS-6-1_002
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2

  Amir Zarrinhaghighi - Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
  Ali Dehshahri - Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.|Pharmaceutical Sciences Research center, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract:

The rapid spread of SARS-CoV-2 has led researchers to seek novel drugs as well as re-purposing the existing drugs to prevent control or treat COVID-19. An interesting approach is to focus on the molecular pathways which could act as a drug target in this disease. Since the molecular pathways associated with SARS-CoV-2 are still unclear, the SARS-CoV infected patients and the convalescent individuals were selected as the model for SARS-CoV-2 infection and an in silico study was designed to identify the potential pathways which could act as the target for drug molecules. In the next step, the drugs with the ability to target these pathways were selected and introduced as potential compounds for further investigations to finding a drug for COVID-19. The results revealed that lycorine and GW-5074 are two small molecules with the ability to target the selected pathways. Interestingly, these compounds had shown antiviral activity against a broad range of viruses, including SARS-CoV. The results obtained in this in silico study could be considered as a primary study for further investigations.

Keywords:

SARS-CoV-2, COVID-19, molecular pathways, drug candidate

Perma Link

https://www.civilica.com/Paper-JR_TIPS-JR_TIPS-6-1_002.html
COI code: JR_TIPS-6-1_002

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Zarrinhaghighi, Amir & Ali Dehshahri, 2020, An in Silico Approach to Find the Molecular Targets and Potential Candidates for SARS-CoV-2, Trends in Pharmaceutical Sciences 6 (1), https://www.civilica.com/Paper-JR_TIPS-JR_TIPS-6-1_002.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Zarrinhaghighi, Amir & Ali Dehshahri, 2020)
Second and more: (Zarrinhaghighi & Dehshahri, 2020)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 2097
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.